High MCH, High MCV, High-Normal Hematocrit, and Low Platelet Count: Differential Diagnosis
The most likely causes of this constellation of findings are alcohol use disorder, liver disease, vitamin B12/folate deficiency, or hemochromatosis, with thrombocytopenia suggesting either bone marrow suppression from alcohol/liver disease or a concurrent myelodysplastic process.
Primary Diagnostic Considerations
Macrocytosis (High MCV/MCH) Etiologies
The elevated MCV and MCH point to macrocytic processes. Drug therapy and alcohol are the most common causes of macrocytosis in hospitalized patients, followed by liver disease and reticulocytosis 1. Megaloblastic hematopoiesis (B12/folate deficiency) accounts for less than 10% of macrocytosis cases 1.
When MCV exceeds 120 fL, vitamin B12 deficiency becomes the usual culprit 1. However, your patient's high-normal hematocrit makes severe megaloblastic anemia less likely, as these typically present with anemia.
Hemochromatosis Consideration
Hemochromatosis uniquely causes elevated MCV, MCH, and MCHC with increased hemoglobin and hematocrit 2, 3. In C282Y/C282Y homozygotes, mean MCV values are significantly higher (94-95 fL) compared to controls (89-91 fL) 3. This occurs because increased iron uptake leads to greater hemoglobin synthesis in immature erythroid cells 2. The high-normal hematocrit in your case fits this pattern better than B12/folate deficiency.
Thrombocytopenia Integration
The low platelet count narrows the differential significantly:
- Alcohol-related: Causes both macrocytosis and thrombocytopenia through direct bone marrow suppression and splenic sequestration from liver disease
- Liver disease: Portal hypertension leads to splenomegaly and platelet sequestration; cirrhosis impairs thrombopoietin production
- Myelodysplastic syndrome (MDS): Can present with macrocytosis and isolated thrombocytopenia or multilineage cytopenias
- Folate/B12 deficiency: Severe cases cause ineffective thrombopoiesis
Diagnostic Algorithm
Initial Laboratory Workup
Per KDIGO guidelines for anemia evaluation (applicable to macrocytosis workup) 4:
Complete blood count with differential - already done
Absolute reticulocyte count - distinguishes hypoproliferative from hemolytic/hemorrhagic causes
Peripheral blood smear review:
- Macro-ovalocytes and hypersegmented neutrophils → megaloblastic anemia
- Target cells and acanthocytes → liver disease
- Well-filled large erythrocytes → hemochromatosis 2
Serum vitamin B12 and folate levels 4
Liver function tests (AST, ALT, bilirubin, albumin, INR)
Iron studies: Ferritin and transferrin saturation
- Transferrin saturation ≥75% suggests hemochromatosis 3
- If elevated, proceed to HFE genetic testing (C282Y/H63D mutations)
Second-Tier Testing Based on Initial Results
- If B12 low-normal or borderline: Methylmalonic acid and homocysteine levels are useful for confirming B12 deficiency 1
- If liver disease suspected: Hepatitis panel, ultrasound for cirrhosis/splenomegaly
- If unexplained: Bone marrow biopsy to evaluate for MDS, especially if other cytopenias develop
Critical Pitfalls to Avoid
Don't assume anemia is required for B12/folate deficiency: However, the high-normal hematocrit makes this less likely as the primary cause
Recognize hemochromatosis can mimic polycythemia: Macrocytosis elevates hemoglobin/hematocrit levels independently 5, potentially masking other pathology
Alcohol history may be underreported: Directly ask about quantity and frequency; consider CDT (carbohydrate-deficient transferrin) or GGT if suspicion is high
Check for medication causes: Methotrexate, hydroxyurea, antiretrovirals, anticonvulsants, and chemotherapy agents commonly cause macrocytosis 1
Spurious MCHC elevation: Cold agglutinins or lipemia can falsely elevate MCHC 6; warm sample to 37°C if MCHC is also elevated
Most Likely Clinical Scenarios
If patient has alcohol use or liver disease history: This explains both findings completely through direct marrow toxicity and hypersplenism.
If transferrin saturation >75% with no alcohol/liver disease: Pursue hemochromatosis workup with HFE genotyping 3, 7.
If isolated findings without clear cause: Consider MDS, particularly in older patients (>60 years), and proceed to bone marrow evaluation.